Michael Weiser insider trades

Open-market stock purchases and sales by Michael Weiser, Director at Iovance Biotherapeutics, Inc, from SEC Form 4 filings since Dec 31, 2009.

Recent trades

DateStockTradeValue
Jun 16, 2026IOVA Iovance Biotherapeutics, IncBought (not open market)—

Companies traded

  • IOVA Iovance Biotherapeutics, Inc: 2 buys, last Jun 16, 2026
  • ZIOP Ziopharm Oncology Inc: 1 sale, last Dec 30, 2017
  • EMIS Emisphere Technologies Inc: other filings, last May 18, 2017
  • CHTP Chelsea Therapeutics International, Ltd: 2 buys, last Jun 23, 2014
  • MHAN Manhattan Pharmaceuticals Inc: other filings, last Mar 8, 2010
  • HNAB Hana Biosciences Inc: other filings, last Feb 16, 2010

Get free alerts when Michael Weiser files a new trade →